4.7 Review

CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy

Journal

SCIENCE CHINA-LIFE SCIENCES
Volume 60, Issue 5, Pages 468-475

Publisher

SCIENCE PRESS
DOI: 10.1007/s11427-017-9057-2

Keywords

CRISPR/Cas9; gene therapy; in vivo; ex vivo

Categories

Funding

  1. National Natural Science Foundation of China [31371455, 31171318, 81330049]
  2. Science and Technology Commission of Shanghai Municipality [14140900300]

Ask authors/readers for more resources

CRISPR/Cas9 is a versatile genome-editing tool which is widely used for modifying the genome of both prokaryotic and eukaryotic organisms for basic research and applications. An increasing number of reports have demonstrated that CRISPR/Cas9-mediated genome editing is a powerful technology for gene therapy. Here, we review the recent advances in CRISPR/Cas9-mediated gene therapy in animal models via different strategies and discuss the challenges as well as future prospects.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available